Back to Search
Start Over
Supplementary Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Materials
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....967fa8306079a83994166b6b61468dab
- Full Text :
- https://doi.org/10.1158/1078-0432.22481009